User menu

Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.

Bibliographic reference Palm, Thomas ; Figarella-Branger, Dominique ; Chapon, Françoise ; Lacroix, Catherine ; Gray, Françoise ; et. al. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.. In: Cancer, Vol. 115, no. 17, p. 3955-68 (2009)
Permanent URL http://hdl.handle.net/2078.1/23050
  1. LouisDN, OhgakiH, WiestlerOD, CaveneeWK, eds. WHO Classification of Tumors of the Central Nervous System. Lyon, France: IARC Press; 2007.
  2. Hirose Yuichi, Aldape Kenneth, Bollen Andrew, James C. David, Brat Daniel, Lamborn Kathleen, Berger Mitchel, Feuerstein Burt G., Chromosomal Abnormalities Subdivide Ependymal Tumors into Clinically Relevant Groups, 10.1016/s0002-9440(10)64061-8
  3. Huang, Acta Neuropathol (Berl)., 106, 357 (2003)
  4. Mazewski, Cancer Genet Cytogenet., 113, 1 (1999)
  5. Vagner-Capodano, Cancer Genet Cytogenet., 115, 96 (1999)
  6. Zheng, Cancer Genet Cytogenet., 122, 18 (2000)
  7. Dyer Sara, Prebble Emma, Davison Val, Davies Paul, Ramani Pramila, Ellison David, Grundy Richard, Genomic Imbalances in Pediatric Intracranial Ependymomas Define Clinically Relevant Groups, 10.1016/s0002-9440(10)64491-4
  8. Carter, Br J Cancer., 86, 929 (2002)
  9. Rousseau, Mol Cancer., 6, 47 (2007)
  10. Granzow, Cancer Genet Cytogenet., 130, 79 (2001)
  11. Mendrzyk, Clin Cancer Res., 12, 2070 (2006)
  12. Rousseau, Neuropathol Appl Neurobiol., 29, 574 (2003)
  13. Korshunov Andrey, Neben Kai, Wrobel Gunnar, Tews Bjoern, Benner Axel, Hahn Meinhard, Golanov Andrey, Lichter Peter, Gene Expression Patterns in Ependymomas Correlate with Tumor Location, Grade, and Patient Age, 10.1016/s0002-9440(10)63530-4
  14. Modena, J Clin Oncol., 24, 5223 (2006)
  15. Taylor, Cancer Cell., 8, 323 (2005)
  16. Lukashova, Acta Neuropathol (Berl)., 113, 325 (2007)
  17. Suarez-Merino, Neuro Oncol., 7, 20 (2005)
  18. Hanahan, Cell., 100, 57 (2000)
  19. Tihan, Mod Pathol., 21, 165 (2008)
  20. Zamecnik, Mod Pathol., 16, 980 (2003)
  21. Argiropoulos, Oncogene., 26, 6766 (2007)
  22. Cillo, J Cell Physiol., 188, 161 (2001)
  23. Katoh, Cancer Biol Ther., 4, 1050 (2005)
  24. Pardal, Nat Rev Cancer., 3, 895 (2003)
  25. Zhang, Mol Cell Biochem., 307, 101 (2008)
  26. Ward, Curr Biol., 16, 2352 (2006)
  27. Hallahan, Cancer Res., 64, 7794 (2004)
  28. Deng, Exp Cell Res., 313, 1033 (2007)
  29. Piccirillo, Nature., 444, 761 (2006)
  30. Vandeputte, Glia., 38, 329 (2002)
  31. Cassimeris, Curr Biol., 14, R1000 (2004)
  32. Logan, Annu Rev Cell Dev Biol., 20, 781 (2004)
  33. Taipale, Nature., 411, 349 (2001)
  34. Bennetto, Neuropathol Appl Neurobiol., 24, 434 (1998)
  35. Ho, J Neurooncol., 54, 77 (2001)
  36. Coller, PLoS Genet., 3, e146 (2007)
  37. Scholzen, J Cell Physiol., 182, 311 (2000)
  38. Johnson, Proc Natl Acad Sci U S A., 91, 12823 (1994)
  39. Johnson, Curr Mol Med., 6, 731 (2006)
  40. Matsumura Itaru, Tanaka Hirokazu, Kanakura Yuzuru, E2F1 and c-Myc in Cell Growth and Death, 10.4161/cc.2.4.428
  41. Olson, Cancer Res., 67, 4005 (2007)
  42. Preusser, Am J Clin Pathol., 124, 543 (2005)
  43. Easwaran, Cancer Res., 63, 3145 (2003)
  44. Chan, Am J Surg Pathol., 22, 816 (1998)
  45. Preusser, Acta Neuropathol (Berl)., 109, 211 (2005)
  46. Hazan, Ann N Y Acad Sci., 1014, 155 (2004)
  47. Bringuier, Cancer Res., 53, 3241 (1993)
  48. Michalowski, Cancer Genet Cytogenet., 166, 74 (2006)
  49. Wagner, FEBS J., 274, 2968 (2007)
  50. Akin, Cell Mol Neurobiol., 25, 697 (2005)
  51. Bapat, Semin Cancer Biol., 17, 204 (2007)